Cambridge Cancer Genomics Provides A More Efficient Way To Track Effective Cancer Treatments
John Cassidy’s family has been the leader of cancer research for almost three generations now. The Cambridge-educated co-founder and CEO of Cancer Diagnostics Company Cambridge Cancer Genomics were just following in his father and grandfather’s footsteps when he dove into researching the disease in college.
New Drug For Extremely Deadly Cancer
Acute lymphoblastic leukemia (ALL) is an extremely deadly cancer, but a new treatment option could result in a higher survival rate. Are you aware of this very deadly cancer that spreads quickly throughout your entire body? Majority of people are unaware with B-cell acute lymphoblastic leukemia, a quickly growing cancer that happens when the bone marrow makes too many B-cell lymphocytes, a type of white blood cell.